Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

Barry A. Borlaug, Dalane W. Kitzman, Melanie J. Davies, Søren Rasmussen, Eric Barros, Javed Butler, Mette Nygaard Einfeldt, G. Kees Hovingh, Daniél Vega Møller, Mark C. Petrie, Sanjiv J. Shah, Subodh Verma, Walter Abhayaratna, Fozia Z. Ahmed, Vijay Chopra, Justin Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtech Melenovsky, Julio Núñez, Eduardo Perna, Morten Schou, Michele Senni, Peter van der Meer, Dirk Von Lewinski, Dennis Wolf, Mikhail N. Kosiborod

Open source

DOI
10.1038/s41591-023-02526-x
Published
2023-08-27
Container
Nature Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-023-02526-x,
  title = {Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial},
  author = {Barry A. Borlaug and Dalane W. Kitzman and Melanie J. Davies and Søren Rasmussen and Eric Barros and Javed Butler and Mette Nygaard Einfeldt and G. Kees Hovingh and Daniél Vega Møller and Mark C. Petrie and Sanjiv J. Shah and Subodh Verma and Walter Abhayaratna and Fozia Z. Ahmed and Vijay Chopra and Justin Ezekowitz and Michael Fu and Hiroshi Ito and Małgorzata Lelonek and Vojtech Melenovsky and Julio Núñez and Eduardo Perna and Morten Schou and Michele Senni and Peter van der Meer and Dirk Von Lewinski and Dennis Wolf and Mikhail N. Kosiborod},
  year = {2023},
  journal = {Nature Medicine},
  doi = {10.1038/s41591-023-02526-x},
  url = {https://doi.org/10.1038/s41591-023-02526-x}
}

RIS

TY  - JOUR
TI  - Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
AU  - Barry A. Borlaug
AU  - Dalane W. Kitzman
AU  - Melanie J. Davies
AU  - Søren Rasmussen
AU  - Eric Barros
AU  - Javed Butler
AU  - Mette Nygaard Einfeldt
AU  - G. Kees Hovingh
AU  - Daniél Vega Møller
AU  - Mark C. Petrie
AU  - Sanjiv J. Shah
AU  - Subodh Verma
AU  - Walter Abhayaratna
AU  - Fozia Z. Ahmed
AU  - Vijay Chopra
AU  - Justin Ezekowitz
AU  - Michael Fu
AU  - Hiroshi Ito
AU  - Małgorzata Lelonek
AU  - Vojtech Melenovsky
AU  - Julio Núñez
AU  - Eduardo Perna
AU  - Morten Schou
AU  - Michele Senni
AU  - Peter van der Meer
AU  - Dirk Von Lewinski
AU  - Dennis Wolf
AU  - Mikhail N. Kosiborod
PY  - 2023
JO  - Nature Medicine
DO  - 10.1038/s41591-023-02526-x
UR  - https://doi.org/10.1038/s41591-023-02526-x
ER  - 

APA

Borlaug, B. A., Kitzman, D. W., Davies, M. J., Rasmussen, S., Barros, E., Butler, J., Einfeldt, M. N., Hovingh, G. K., Møller, D. V., Petrie, M. C., Shah, S. J., Verma, S., Abhayaratna, W., Ahmed, F. Z., Chopra, V., Ezekowitz, J., Fu, M., Ito, H., Lelonek, M., Melenovsky, V., Núñez, J., Perna, E., Schou, M., Senni, M., Meer, P. V. D., Lewinski, D. V., Wolf, D., & Kosiborod, M. N. (2023). Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nature Medicine. https://doi.org/10.1038/s41591-023-02526-x

Source records